This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Subacute sclerosing panencephalitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

subacute sclerosing pancencephalitis

  • a rare, fatal, late complication of measles infection. One case of SSPE occurs for every 25,000 measles infections
  • in children infected under the age of two, the rate is one in 8000 infections
  • developing measles under one year of age carries a risk of SSPE 16 times greater than in those infected over five years of age
  • median interval from measles infection to onset of symptoms is around seven years but may be as long as two to three decades
  • SSPE may follow an unrecognised measles infection. Wild measles virus has been found in the brain of SSPE cases including those with no history of measles disease

High titres of measles antibody are usually present in the blood and CSF.

Death is inevitable but long periods of survival have been reported.

Reference:

  1. Immunisation Against Infectious Disease - "The Green Book".Chapter 21 Measles (August 2006)


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.